project - Research and innovation

Alternatives to Veterinary Antimicrobials
Alternatives to Veterinary Antimicrobials

Ongoing | 2020 - 2024 Austria, Belgium, Denmark, France, Germany, Netherlands, Spain, United Kingdom
Ongoing | 2020 - 2024 Austria, Belgium, Denmark, France, Germany, Netherlands, Spain, United Kingdom
Affichage actuel du contenu de la page dans la langue maternelle, si disponible

Objectives

AVANT is a multi-actor inter-sectorial project aimed at developing alternatives to antimicrobials for the management of bacterial infections in pigs, especially diarrhoea during the weaning period, as the major indication for antimicrobial use in livestock in Europe. During pre-clinical studies, efficacy, toxicity, and mode of action of these interventions is tested, and their dosage and formulation optimized. The results and a survey for veterinarian-, farmer- and consumers perception of antimicrobial alternatives, will be used together with legal and economic considerations to select three interventions for large-scale farm trials, assessing clinical efficacy and impact on antimicrobial use.

Objectives

AVANT is a multi-actor inter-sectorial project aimed at developing alternatives to antimicrobials for the management of bacterial infections in pigs, especially diarrhoea during the weaning period, as the major indication for antimicrobial use in livestock in Europe. During pre-clinical studies, efficacy, toxicity, and mode of action of these interventions is tested, and their dosage and formulation optimized. The results and a survey for veterinarian-, farmer- and consumers perception of antimicrobial alternatives, will be used together with legal and economic considerations to select three interventions for large-scale farm trials, assessing clinical efficacy and impact on antimicrobial use.

Activities

The AVANT portfolio comprises a variety of alternatives for treatment or prevention of diarrhoea and/or respiratory infections, namely:



• Gut-stabilizing interventions based on a symbiotic (pre- and probiotic) product and faecal microbiota transplantation

• Novel veterinary medicinal products containing bacteriophages and polymers for targeted treatment of enterotoxigenic E. coli infections

• Immuno-stimulating injectable and feed additive products

• Alternative feeding strategies targeting sows and piglets



All steps are supported by regulatory advice for quick market entry post-project. Generated and existing data on antimicrobial use, pig demographics and projected consumption of pork, will be used in mathematical modelling to estimate the reduction in antimicrobial use that could be achieved by 2030, if the AVANT alternatives were widely adopted in pig production.

Additional information

AVANT has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 862829.

Project details
Main funding source
Horizon 2020 (EU Research and Innovation Programme)
Project acronym
AVANT
Agricultural sectors
  • Livestock (generic)
  • Pigs

€ € 6 537 033,75

Total budget

Total contributions including EU funding.

€ € 5 999 905,02

EU contribution

Any type of EU funding.

Affichage actuel du contenu de la page dans la langue maternelle, si disponible

Contacts

Stefan Weiss

Project coordinator

  • University of Copenhagen

    Project coordinator

Project partners

  • Biomin

    Project partner

  • Cooperl

    Project partner

  • Easy-Agricare

    Project partner

  • Federation of Veterinarians of Europe

    Project partner

  • Klifovet

    Project partner

  • Ovejero Laboratories

    Project partner

  • Royal Veterinary College

    Project partner

  • RTDS Group

    Project partner

  • Schothorst Feed Research

    Project partner

  • Danish Agriculture & Food Council F.m.b.A. SEGES

    Project partner

  • Swiss Federal Institute of Technology, Zurich

    Project partner

  • Universidad Complutense de Madrid

    Project partner

  • Wageningen Research

    Project partner